Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ulthera

2004 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
$600M LATEST DEAL AMOUNT
Description

Developer of ultrasound based medical devices. The company offers a nonsurgical cosmetic procedure employing therapeutic ultrasound technology that is used to counter the affects of aging on the skin through tightening and lifting skin tissues.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Diagnostic Equipment
Parent Company
Merz Pharma
Primary Office
  • 1840 South Stapley Drive
  • Suite 200
  • Mesa, AZ 85204
  • United States

+1 (877) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ulthera’s full profile, request a free trial.

Ulthera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 30-Jul-2014 $600M 000.00 00000 Completed Generating Revenue
4. IPO 27-Jun-2014 000.00 Cancelled Generating Revenue
3. Later Stage VC (Series C) 08-Feb-2011 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 17-Jan-2008 $22.5M $28M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 13-Dec-2005 $5.5M $5.5M 000.00 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Ulthera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 2,750,000 $0.001000 8% $2 $2 1x $1.33 8.43%
To view this company’s complete Cap Table, request access »

Ulthera Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 03-Feb-2014 000000000000000000 Therapeutic Devices
To view this company’s complete investment and acquisition history, request access »

Ulthera Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
3i Group PE/Buyout Minority 000 0000 000000 0
Apposite Capital PE/Buyout Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0

Ulthera Executive Team (8)

Name Title Board
Seat
Contact
Info
Janice Lipsky Ph.D Vice President, Global Marketing
William Fender Vice President, Operations
Michael Fritts Vice President & General Manager
Michael Peterson Vice President, Research & Development

4 Former Executives

You’re viewing 4 of 8 executives. Get the full list »

Ulthera Board Members (8)

Name Representing Role Since Contact
Info
Michael Slayton Ph.D Self Founder & Board Member 000 0000

7 Former Board Members

You’re viewing 1 of 8 board members. Get the full list »